Interstitial Cystitis

Real-world all-cause healthcare resource utilization and costs among patients with interstitial cystitis/bladder pain syndrome in the United States.

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a persistent and heterogeneous condition diagnosed by exclusion, defined by a bladder-associated unpleasant sensation (e.g. pain, pressure, or discomfort), and affecting patients' quality of life. This real-world study aimed to describe all-cau…

Corrigendum to "Treatment of interstitial cystitis/bladder pain syndrome: Guidelines from the Committee of Female Urology (CUROPF) of the French Association of Urology (AFU)" [The French Journal of Urology 36 (2026) 103169].

Corrigendum to "Diagnosis of interstitial cystitis/bladder pain syndrome: Guidelines from the Committee of Female Urology (CUROPF) of the French Association of Urology (AFU)" [The French Journal of Urology 36 (2026) 103166].

Mesenchymal stem Cells and Extracellular Vesicles in Bladder Dysfunction: Mechanisms and Translational Perspectives.

Bladder dysfunction comprises diverse lower urinary tract disorders lacking treatments that restore tissue integrity and neural control. While mesenchymal stem cells (MSCs) show promise in regenerative urology, their benefits primarily stem from paracrine mechanisms. Consequently, MSC-derived extrac…

Diagnostic Model Development for IC/BPS and Its Subtypes Using Clinical Indicators, Urinary Biomarkers, and Single-Cell Transcriptomic Analysis.

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic, heterogeneous, and often debilitating condition. This condition is often misdiagnosed, as it overlaps significantly with other urinary infections, necessitating the development of new markers and targets to improve diagnosis and ther…

Serum 17β-Estradiol Concentrations in Women With Interstitial Cystitis/Bladder Pain Syndrome: A Retrospective Observational Study.

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a long-lasting, sterile inflammatory disease affecting the lower urinary tract, marked by pelvic pain, urgency, and nighttime urination (nocturia). The marked female predominance of IC/BPS has prompted interest in the potential role of end…

Toward therapnostic integration as a new paradigm for precision management of interstitial cystitis driven by medical-engineering convergence.

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a complex chronic inflammatory disease involving mucosal barrier defects, neurogenic inflammation, mast cell activation, and tissue remodeling. Current diagnosis lacks objective biomarkers, relying instead on symptom assessment and exclusion of…

Effects of functional versus conventional Physiotherapy-Based pain management on symptoms, psychological outcomes, and quality of life in women with Bladder Pain Syndrome: A Randomized Controlled Trial.

Bladder Pain Syndrome (BPS) is a chronic pelvic pain condition characterized by urinary symptoms, psychological distress, and reduced quality of life (QoL). Given its biopsychosocial nature, physiotherapy approaches targeting peripheral and central pain mechanisms may provide broader benefits than s…